LEPR and obesity disorder: We investigated whether reconstituting Lepr selectively in myeloid cells of mice with whole-body Lepr transcriptional blockade, which are characterized by obesity, hyperinsulinemia, and hyperleptinemia35, would alter glucose metabolism.